{"id":"W2914802774","doi":"10.1158/1538-7445.sabcs18-p3-11-05","title":"Abstract P3-11-05: Predictive gene signatures of adjuvant capecitabine benefit in triple negative breast cancer in the FinXX trial","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Epirubicin; Medicine; Oncology; Internal medicine; Docetaxel; Breast cancer; Triple-negative breast cancer; Hazard ratio; Cyclophosphamide; Fluorouracil; Cancer; Gene signature; Chemotherapy; Confidence interval; Gene expression; Colorectal cancer; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586766,0.0005517861,0.0008502335,0.0001109769,0.0001769166,0.0005427302,0.0002627491,0.0004332873,0.002741034],"category_scores_gemma":[0.001070763,0.0001194276,0.0008055618,0.0001618986,0.0003072749,0.0003156797,0.00018482,0.0009797809,0.0002188263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003395632,"about_ca_system_score_gemma":0.0003723339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004547015,"about_ca_topic_score_gemma":0.0009984128,"domain_scores_codex":[0.9996841,0.000180868,0.00001887598,0.00006059828,0.0000267583,0.00002879405],"domain_scores_gemma":[0.9995359,0.0001742359,0.0001030538,0.00003961352,0.00003175232,0.0001155353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8717529,0.00104176,0.05405118,0.0008979618,0.002513474,0.0001375755,0.00004963238,0.002409682,0.008400347,0.0002456418,0.004427552,0.05407236],"study_design_scores_gemma":[0.4111777,0.1583419,0.3889254,0.0004516885,0.009559331,0.0009012086,0.0001518378,0.009331482,0.007959631,0.001906936,0.0111824,0.0001104387],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927191,0.002547591,0.00030913,0.0004074809,0.00008213447,0.0002679817,0.001482483,0.00003545026,0.002148707],"genre_scores_gemma":[0.9948043,0.0004216353,0.000389996,0.0003139356,0.00007117474,0.000245672,0.002398221,0.000007501313,0.00134755],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002741034,"threshold_uncertainty_score":0.009169698,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05386875586804307,"score_gpt":0.4167851853130808,"score_spread":0.3629164294450378,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}